483 Glenmark Pharmaceuticals Mar 2018

483 Glenmark Pharmaceuticals Mar 2018

Lucas Leake FDA$119.00 - Available Now

FDA investigators audited the Glenmark Pharmaceuticals - Pune, India facility and issued inspectional observations (via FDA 483) on 22 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Mar 2018
  • Location: Pune, India
  • FEI: 3014026060
Add To Cart